Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin)
October 28, 2013 · Comments Off
A University of Colorado Cancer Center study published in the journal PLoS One shows that, like overflowing a dam, colorectal cancer may resist the drug bevacizumab (Avastin), by switching dependence from the main flow of VEGF-A to the "tributaries" of related growth factors including VEGF-C, VEGF-D and placental growth factor.
CU Cancer Center Study: Young patients with metastatic colorectal cancer at higher risk
September 30, 2013 · Comments Off
AURORA, Colo. – Younger patients with colorectal cancer that has spread to other parts of...
Wait times up 78 percent at VA for colorectal cancer procedures
August 26, 2013 · Comments Off
A study published in the August print issue of the Journal of Oncology Practice shows that from 1998-2008, wait times for colorectal cancer operations at Veterans Administration hospitals increased from 19 to 32 days. But researchers think longer waits may be a reflection of several unmeasured variables including more careful care, staffing, and patient conditions or preferences.
AACR News: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
April 8, 2013 · Comments Off
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
Study revises colorectal cancer risk down and other cancer risks up for women with Lynch Syndrome
February 26, 2013 · Comments Off
A cooperative study that included the University of Colorado Cancer Center, published in this month's issue of the Journal of the National Cancer Institute, revises the risk of colorectal cancer down but other cancers up for women with Lynch Syndrome who have had endometrial cancer.
A diet of resistant starch helps the body resist colorectal cancer
February 19, 2013 · Comments Off
A University of Colorado Cancer Center review published in this month's issue of the journal Current Opinion in Gastroenterology shows that resistant starch helps the body resist colorectal cancer through mechanisms including killing pre-cancerous cells and reducing inflammation that can otherwise promote cancer.
As colorectal cancer gets more aggressive, treatment with grape seed extract is even more effective
January 16, 2013 · Comments Off
This study shows that many of the same mutations that allow colorectal cancer cells to metastasize and survive traditional therapies make them especially sensitive to treatment with GSE," says Molly Derry, doctoral candidate in the lab of Rajesh Agarwal, PhD, investigator at the CU Cancer Center and professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.
A recipe for increased colorectal cancer screening rates
August 14, 2012 · Comments Off
Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability...
NTRK1: a new oncogene and target in lung cancer
August 14, 2012
ALK alk drug lung cancer ALL amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship cell signaling clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Today is the day! Enjoy some blueberry pancakes and dress in all blue for Dress in Blue day to increase... http://t.co/LnYh9iT1lW
One last reminder. Wear blue tomorrow for Dress in Blue Day! http://t.co/dNKEDueKNv
In Health Care, Choice Is Overrated. We're glad our patient got the second opinion needed. Hope others can too. http://t.co/3T9CrAj8E2
President Obama has declared March National Colorectal Cancer Awareness Month! Remember to wear blue this Friday... http://t.co/neqgyKCzAC